HTGM - HTG Molecular Diagnostics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue21,503.89414,759.5675,132.734,041.575
Cost of Revenue17,516.50414,648.5174,135.8843,335.511
Gross Profit3,987.39111.05996.846706.064
Operating Expenses
Research Development172.005319.9167,900.3114,601.718
Selling General and Administrative19,974.61617,513.74217,427.77714,994.41
Non Recurring----
Others----
Total Operating Expenses37,663.12532,482.17529,463.97222,931.639
Operating Income or Loss-16,159.231-17,722.608-24,331.242-18,890.064
Income from Continuing Operations
Total Other Income/Expenses Net-291.161-1,234.48-1,698.19-2,497.538
Earnings Before Interest and Taxes-16,159.231-17,722.608-24,331.242-18,890.064
Interest Expense-901.82-1,307.674-1,867.466-1,719.475
Income Before Tax-16,450.392-18,957.096-26,029.432-21,387.602
Income Tax Expense3.5262.92110.11810.189
Minority Interest----
Net Income From Continuing Ops-16,453.918-18,960.017-26,039.55-21,397.791
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-16,453.918-18,960.017-26,039.55-21,397.791
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-16,453.918-18,960.017-26,039.55-22,726.385